“We spend numerous hours a day updating that tracker because what is critical is real-time information that researchers and scientists can respond to. … As I've been speaking to colleagues, ranging from NIH to these large companies, they're using that daily in their prioritization exercises to determine what they can accelerate and what the potential opportunities are.” 

Keeping track of rapid-pace global developments in treatments and vaccines for COVID-19 may seem to be an uphill battle. But since February, Esther Krofah’s team at FasterCures has been producing exactly that: a real-time tool that, as of late May 2020, is monitoring development of more than 200 treatments and 140 vaccines.

Krofah, who assumed her leadership role just months before the coronavirus crisis, continues to build on the organization’s legacy of partnerships with government, industry and patient groups: “We believe time equals lives, and so these organizations, these institutions, have been part of our journey over the last almost three decades. And as we come to a time like this with COVID, we need that foundation of trust. … There's that recognition that individuals, families, patients is what drives us day-in and day-out.”